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Synovial sarcoma is characterized by a prevalent 
chromosomal translocation, t(X;18)(p11 ;q11). As a result 
of this translocation the SYT gene on chromosome 18 
fuses to either the SSX1 or the SSX2 gene on the X 
chromosome. In this study, we generated polyclonal 
antibodies against the SYT and SSX2 proteins. These 
antibodies specifically detected both these proteins 
and the SYT-SSX fusion proteins in transfected COS-1 
cell extracts. Indirect immunofluorescence analysis of 
COS-1 cells expressing tagged or untagged SYT, SSX2, 
SYT-SSX1 or SYT-SSX2 indicated that all these proteins 
are localized in the nucleus, excluding the nucleoli. 
The SSX2 protein exhibited a diffuse staining pattern 
whereas both the SYT and SYT-SSX proteins appeared 
in several nuclear dots. Similar nuclear dots were also 
detected in primary synovial sarcoma cells growing in 
a short-term in vitro culture. Double immunofluores­
cence in conjunction with confocal laser-scanning 
microscopy revealed that the SYT and SYT-SSX nuclear 
dots do not co-localize with known nuclear structures 
as e.g. coiled bodies, SC35 interchromatin granules or 
PML bodies. The similar nuclear localization patterns 
of SYT and SYT-SSX suggest that the SYT-SSX fusion 
proteins are directed to SYT-associated nuclear do­
mains where an abnormal function may be exerted.
INTRODUCTION
Cytogenetic abnormalities, numerical and structural, are frequently 
found in human hematopoietic and solid tumors. Mesenchymal 
tumors often carry chromosomal translocations, sometimes as a 
single cytogenetic anomaly ( I ). The recent molecular cloning of 
the corresponding translocation breakpoints has revealed that 
segments of two distinct genes become juxtaposed, resulting in 
the generation (if chimeric proteins with new functional properties 
(2,3). Generally, the DNA binding domain of a transcription 
factor becomes fused to a transactivating domain of another 
transcription factor, resulting in a chimeric protein with altered 
transcription regulating activity.
The functional consequences associated with the production of 
chimeric proteins have been studied most extensively in peripheral 
primitive neuroectodermal tumors of childhood, also designated 
as Ewing tumors. These malignancies are characterized by the 
presence of variant translocations with consistent involvement of 
the EWS gene, from the chromosomal region 2 2q l2 , and 
members of the ETS family of transcription factors, such as FLI1, 
ERG, ATV1, E 1AF or FEV (3—5). TTie precise function of the 
EWS protein has not yet been elucidated although it has been 
found that a carboxyl-terminal domain is able to bind RNA and 
an amino-terminal domain exhibits transactivating properties (6 ). 
As a consequence of the chromosomal translocations, the 
carboxyl-terminal RNA binding domain of EWS is replaced by 
the DNA binding domain of a transcription factor. This results in 
a hybrid protein with altered transcriptional activation properties 
and a strong transforming potential, as has been demonstrated for 
the EWS-FLI1 fusion protein (6- 8 ).
Also in synovial sarcomas, a recurrent chromosomal transloca­
tion, t(X;18)(pll.2;qll.2), has been found (9). The t(X; 18)(p 11.2; 
qll,2 ), or complex variants thereof, frequently occurs as the sole 
cytogenetic abnormality and is presumably causally related to 
synovial sarcoma development (1,9,10). Recently, using somatic 
cell hybrids and fluorescence in situ hybridization analysis with 
yeast artificial chromosome and cosmid probes, we and others 
have identified two alternative and mutually exclusive Xpll.2 
breakpoints, suggesting that a single gene on chromosome 18 
may be fused to one of two different genes on the X chromosome 
( l l _ 1 5 ) .  This hypothesis was subsequently validated by the 
cloning of the t(X; 18) breakpoints, showing that a novel gene, 
SYT on chromosome 18, is disrupted and juxtaposed to one of 
two related but distinct novel genes, SSX1 or SSX2 on the X
chromosome (16-19).
At present, the biological function of the SYT protein is still 
elusive. The SYT amino acid sequence is composed of 387 
residues, being rich in glutamine, proline and glycine (19,16 and 
14%, respectively), and comparison with known protein sequences 
from databases provided scant information about possible 
functional domains. Only three potential SH2 binding domains, 
one potential SH3 binding domain and an annex in-like imperfect 
direct repeat could be recognized in the SYT sequence (17,20). 
In addition, SYT contains several stretches of glutamine and 
proline residues which may be indicative of a role in transcription
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activation (21). Evaluation of mRNA levels in human and mouse 
tissues has shown that the SYT gene is widely expressed (17,20). 
mRNA in situ hybridization studies uncovered that in early 
mouse development, SYT is predominantly expressed in certain 
cartilaginous and neuronal tissues and that in adult mice, testicular 
SYT expression is restricted to primary spermatocytes (20).
Several distinct but highly homologous SSX genes have been 
identified on the X chromosome (22). Full-length cDNAs of three 
members of this gene family have thus far been cloned, and all 
were found to encode putative proteins of 188 amino acids 
(19,22). Inspection of the amino acid sequences of the SSX 
proteins disclosed an acidic carboxyl-terminal domain, an amino- 
terminal region with homology to a Krtippel-associated box 
(KRAB) domain, and consensual sequences for N-glycosylation 
and tyrosine phosphorylation sites (19,22). The KRAB domain 
has been identified in a subgroup of zinc finger proteins, where 
it functions as a transcriptional repressor (23,24). Even though 
SSX proteins do not contain DNA binding sequences, the 
presence of an acidic domain and a putative KRAB domain 
indicates that they may be involved in transcription regulation. In 
contrast to the ubiquitous SYT expression, SSX transcripts have 
only been detected in the testis and, at lower levels, the thyroid 
gland (17,19). Therefore, these expression studies indicate that at 
least one consequence of the SYT-SSX fusion is the ectopic 
expression of SSX sequences in synovial sarcoma precursor cells. 
Moreover, it was recently shown that ectopic SSX2 expression 
may occur in several different types of tumors, suggesting that 
additional mechanisms other than fusion with SYT may be at
work (25).
In the majority of synovial sarcoma cases, SYT-SSX fusion 
genes encode proteins comprised of the first 379 amino acids of 
SYT juxtaposed to the last 78 amino acids of either SSX1 or 
SSX2, thereby excluding the putative KRAB domain (18,19,26). 
Less frequent variant fusion genes have also been identified 
(18,19,26). Since most of the SYT sequence is usually present in 
the hybrid proteins, it is conceivable that addition of the 
carboxyl-terminal segment of SSX will impart a new or modified 
function to the SYT protein, thereby triggering tumor development.
Here, we report the production of specific polyclonal anti­
bodies against the SYT and SSX proteins. These antibodies were 
used to determine the subcellular localization of these proteins 
and their respective fusion products in transfected COS-1 cells 








































Figure 1. Schematic representation of (tie SYT. SS.V\ ami SYT-SSX 
constructs. (A) (1ST' fusion constructs containing total SYT (C!ST SYT’-l), 
C-ierminal SYT’ (CiST-SYT-2K NMerminal SYT ((1ST SYT-.*). a central 
segment of SSX2 IliST  S S X M ) or<Meiminal SSX.! « ¡ST  SSX2-.2). The 
CiST-SYT-3, GST--SSX2-1, and CiST SSX2 2 proteins weie used to generate 
antibodies C44, and OH), respectively. A SYT M ammo acid jvptide 
(SYTPHP1> was used to generate rabbit polyclonal antibody RA„'(HR (B)SYT, 
SSX 2, SYT-SSX I . and SYT' SSX 2 c ON As cloned into appmpnate eukaryotic 
expression vectors enabling the production of tagged (VSY, H.Ati) and 
untagged proteins. Arrowheads indicate the must common breakpoints, 
resulting in the SYT-SSX fusion prole ins, as depicted.
Production and specificity of antibodies against SYT 
and SSX2
As a first approach towards the elucidation of the function of the 
synovial sarcoma t(X;18)-associated gene products, we generated 
polyclonal antibodies against the SYT and SSX proteins. 
Full-length SYT and SSX2 cDNAs were isolated and different 
segments of these cDNAs were cloned into pGEX vectors to 
produce glutathione-S-txansferase (GST) fusion proteins (Fig. 1 A). 
Since the SSX 1 and SSX2 proteins are highly homologous (81 % 
identity), we only used one of them, SSX2 , to generate an 
anti-SSX polyclonal antiserum. A GST-SYT fusion protein 
containing the first 158 amino acids of SYT (designated 
GST-SYT-3) (Fig. 1 A) was purified from Escherichia coli and 
used to generate rabbit polyclonal antiserum C44. Similarly, two
GST-SSX2 fusion proteins containing amino acids 25™ 154 
(GST-SSX2-1) and amino acids 155 1SH ((¡ST SSX2-2) were 
expressed and purified from lucoli and used to generate rabbit 
antisera B39 and C90, respectively (Fig, I A). Additionally, a 
polyclonal antiserum (RA2009) was raised auainst a synthetic 14 
amino acid peptide from the SYT carboxyl-terminal region. All 
polyclonal antibodies were tested by immunoblotlinu and shown
< r
to specifically recognize the antigens against which they were 
raised (Fig. 2A and data not shown ).
The deduced amino acid sequences of the SYT, SSX, and 
SYT-SSX proteins predict molecular weights ol’49t 25 and 58 kDa, 
respectively. However, in vitro transcription and translation of the 
respective cDNAs yielded proteins with slower mobilities after 
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Kigure 6. Putative bipartite nuclear localization signals found after inspection 
of the SSX I, SSX2, and SSX3 protein sequences (22). Baste amino acids 
{lysine and arginine) are shown in bold type and the iwo basic amino acid 
clusters identified according to Dingwall and Laskey (30) are underlined.
The finding that both SYT and SYT-SSX proteins are localized 
in particular subnuclear domains is of interest since other 
cancer-associated proteins, such as PML, WT1, BRCA1, Rb, and 
TP53, have also been found to be present in subnuclear domains
(32.37), For instance, the BRCA1 protein displays a distinct
subnuclear distribution pattern related to the cell cycle phase and 
has been associated with meiotic synaptonemal complexes (37). 
Furthermore, the Rb protein is bound to the nuclear matrix during 
early GI phase, being particularly concentrated at the nuclear 
periphery and in the nucleolus (34). The PML protein is normally 
localized in nuclear bodies, in association with other proteins 
(38). However, when expressing the PML-RARafusion protein, 
acute promyelocytic leukemia cells present morphologically 
altered PML bodies (33,35). The PML-associated nuclear bodies 
represent one subtype among several nuclear bodies which have 
been characterized morphologically and biochemically and 
include coiled bodies, GATA nuclear bodies and RNA cleavage 
bodies (27), The coiled bodies were the first to be characterized 
and are composed of factors such as p80 coilin, U-snRNPs (Ul, 
U2, U4/U6, and U5), and Sm-proteins (27,28). In this report, 
double immunofluorescence assays indicated that the SYT and 
SYT-SSX domains do not co-localize with either coiled bodies 
(mAbs 4G3, 9A9, and Y12), splicing factor interchromatin 
granules (mAbs 4G3, 9A9, Y12, and anti-SC35) or PML bodies 
(mAb 5E10). This finding suggests that the SYT/SYT-SSX dots 
are associated with a new class of subnuclear domains. Further 
studies will have to be performed to disclose what the function of 
such nuclear domains may be in normal and abnormal (cancer)
cellular growth.
Isolation of cDNAs and plasmid constructs
The human fibrosarcoma HT-1080 and the testis 5' stretch cDNA
libiaries from Clontech were employed for screening, using
essentially the same procedures as described before (12 ,2 2 ).
Several clones were isolated and full-length SYT and SSX2
cDNAs were subcloned into pT7T3 (Pharmacia) and pGEM7zf
(Promega) cloning vectors for further manipulations. The SYT-
SSX1 and SYT--SSX2 cDNAs were obtained by ligating restriction
digested SYT-SSX RT-PCR products into a SYT cDNA cloned 
in the pT7T3 vector.
For bacterial expression of glutathione-S-transferase (GST) 
fusion proteins, cDNA fragments from the SYT and SSX2 genes 
were cloned in-frame into pGEX vectors (Amrad). A full-length 
SYT cDNA, a carboxyl-terminal fragment including amino acids
159 to 387, and a fragment including the first 158 amino acids were 
cloned in-frame into an appropriate pGEX vector (see Fig. 1 A). 
SSX2 fragments including amino acids 25-154 and amino acids 
155-188 were also cloned into appropriate pGEX vectors (Fig. 1 A).
For eukaryotic expression, the full-length SYT cDNA was 
cloned into the EcoRl site of the pSG5 vector (Stratagene). The 
SYT cDNA was tagged with the vesicular stomatitis virus (VS V) 
glycoprotein sequence (YTDIEMNRLGK) by in-frame cloning 
between the Smal and Xhol sites of the pSG8-VSV vector 
(derived from the pSG5 vector and kindly provided by Dr Edwin 
Cuppen). In addition, The SYT cDNA was tagged with the FLAG 
tag (DYKDDDDK) by inserting in-frame the same Smal-Xhol 
SYT fragment into the pSuperCATCH vector (kindly provided by 
Dr C. Hovens). This vector is derived from the pCATCH vector 
but bears an extended multiple cloning site (39). The full SSX2 
cDNA was cloned between the EcoRl and Hindlll sites of the 
pSG8 vector and into the Smal site of the pSG8-VSV vector. 
Furthermore, a Stul-SalL SSX2 fragment was cloned between the 
EcoRV and SalI sites of the pCATCH vector, so deleting the first 
24 amino acids of the SSX2 cDNA. The SYT-SSX 1 and 
SYT-SSX2 chimeric cDNAs were inserted between the EcoRl 
and Hindlll sites of the pSG8 vector. These cDNAs were also 
FLAG tagged by in-frame insertion of the SYT-SSX 1 cDNA 
between the EcoRl and Xbal sites of the pSuperCATCH/BF 
vector, a pSuperCATCH vector with a filied-in Bam tll site, and 
the SYT-SSX2 cDNA between the Smal and Spkl sites of the 
pSuperCATCH vector. The correct orientation and in-frame 
cloning of the constructs was confirmed by restriction digestion 
analysis and DNA sequencing. The corresponding proteins are 
schematically depicted in Figure 1. Sequencing was performed in 
both orientations using vector-specific oligonucleotides and the 
ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction 
Kit (Perkin Elmer) and an automated DNA sequencer (ABI 373A, 
Applied Biosystems).
Bacterial expression and generation of polyclonal antibodies
The GST-SSX2 fusion proteins were expressed and purified 
following published methods (40). Briefly, logarithmically grown 
E.coli DH5a cells carrying the pGEX~SSX2 constructs were 
induced with 0.1 mM of isopropyl- fi-D-thi ogalactopyranoside for 
3-5 h at 37 °C. The cells were pelleted, resuspended in 1/25 
volume of ice-cold PBS, and lysed by sonication. Triton X-100 
(Fluka) was added to a final concentration of 1%, and then the 
lysate was centrifuged at 5000 g to pellet insoluble material.
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Glutathione-agarosebeads (Sigma) were added to the supernatant 
traction, incubated for 30 min at 4°C, and washed three times 
with PBS. To elute GST-SSX2 fusion proteins, the beads were 
resuspended in 5 mM reduced glutathione (Sigma)/50 mM Tris 
pH 8.0 solution and incubated with agitation for at least 2 min at 
room temperature.
Probably due to the hydrophobic nature of the SYT protein, the 
GST-S YT fusion proteins were not amenable to solubilization by 
the previous method (data not shown). Thus, instead we used 
another method adapted from Frangioni and Neel (41) through 
which GST-SYT-3, but not GST-S YT-1 mid -2, were purified. 
Briefly, expression was carried out as mentioned above, the 
bacterial pellet was washed with ice-cold STE buffer (10 mM Tris 
pH 8.0,150 mM NaCl, 1 mM EDTA) and resuspended in 1/50 the 
volume of the bacterial culture in ice-cold STE buffer containing 
100 |Hg/ml of lysozyme. After incubating for 15 min on ice, 
dithiothreitol, phenylmethylsulphonyl fluoride (PMSF), and 
N-lauroylsarcosine were added to final concentrations of 5 mM, 
1 mM, and 1.5%, respectively, and the mixed suspension was 
lysed by sonication. The lysate was centrifuged at 11 000 g to 
remove insoluble debris, and Triton X-100 was added to the 
supernatant to a final concentration of 4%. Glutathione-agarose 
beads were added to the lysate, and the GST-SYT-3 protein was 
purified as mentioned above. The concentration and purity of the 
eluted proteins were estimated by conventional SDS-PAGE. The 
GST fusion proteins were then applied for rabbit immunization 
following standard procedures, resulting in the antisera C44 
(anti-GST-SYT-3), B39 (anti-GST-SSX2-l), and C90 (anti-GST- 
SSX2-2). The antiserum RA2009 was obtained by immunizing 
rabbits with a synthetic 14 amino acid SYT peptide corresponding 
to residues 264-277 (YSGQEDYYGDQYSH) (Genosys Bio­
technologies Inc.). All antisera were tested on Western blots to 
evaluate their specificity and were affinity purified using Affi-Gel 
Protein A agarose (Bio-Rad), according to the manufacturer’s 
recommendations, to be used in immunofluorescence assays.
Western blot analysis
Transfected COS-1 cells were lysed following standard methods 
(42). Briefly 40-48 h after transfection, cells were washed twice 
with ice-cold PBS and lysed by incubating for 30 min in ice-cold 
RIPA buffer (50 mMTris pH 8.0, 150 mM NaCl, 1%NP40,0.5% 
Na deoxycholate, 0.1% SDS, 0.1% 2-mercaptoethanol, 1 mM 
PMSF, 4.8 jug/nil aprotinin). The cells were then scraped off and 
spun down at 12 000 g for 2 min at 4°C, Supernatants were 
collected and aliquots were mixed with a 5 x SDS-PAGE sample 
buffer (62.5 mM Tris pH 6 .8 , 20% glycerol, 2% SDS, 5%
2-mercaptoethanol, 0.025% bromophenol blue), heat denatured, 
and analyzed on 10 or 12% SDS-PAGE gels. Electrophoresed 
samples and unstained molecular markers (Bio-Rad) were then 
electroblotted onto nitrocellulose filters (Schleicher & Schuell) in 
transfer buffer (192 mM glycine, 25 mM Tris, 20% ethanol), 
using a Bio-Rad Mini Trans-Blot Cell. The filters were stained 
with 0.2% Ponceau S (Sigma) to assess the efficiency of blotting 
and afterwards blocked (0.4% gelatin, 10 mM Tris pH 7.5,350 mM 
NaCl) for 30 min at 37 °C. After blocking, filters were incubated 
with the primary antibody in RIA buffer (10 mM Tris pH 7.5,
160 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% Na 
deoxycholate) for 1 h at room temperature. As primary antibodies, 
we used the anti-SYT (C 44,1:1000 dilution and RA2009, 1:1000 
dilution) and anti-SSX2 (B39, 1:5000 dilution and C90, 1:3000
dilution) polyclonal antibodies and the anti-VSV [P5D4, 1:1500 
diluted (43)1 and anti-FLAG (M5, 1:3(K) diluted, Eastman Kodak 
Company) monoclonal antibodies. The filters were washed three 
times in RIA buffer and incubated with alkaline phosphatase- 
conjugated secondary antibodies (1:3000 dilution, Bio-Rad) in 
RIA buffer, for 1 h at room temperature. The filters were developed 
using the Alkaline Phosphatase Conjugate Substrate Kit according 
to manufacturer's instructions (Bio-Rad).
In vitro transcription and translation
In vitro transcription and translation reactions were {X'tiormed with 
the TnT Coupled Reticulocyte Lysate Systems and tRNAnsccml 
Non-Radioactive Translation Detection System from Promega, 
followiim the manufacturer's protocols.
Synovial sarcoma cells
Tumor fragments obtained from a biphasie synovial sarcoma 
resected from a 43-year-old male were transplanted s.c, into the 
inter-scapular region of nude mice (N;NIH[s| -  nu/nu) maintained 
under speeifie-pathouen-free conditions. When the tumor volume 
reached -1500 m nr, it was resected and divided into small 
fragments 5-6 mm diameter and reimplanted s.c. into nude mice 
or transferred to culture plates in RPM1 medium, supplemented 
with 16% fetal calf serum and antibiotics,
Transfections and indirect immunonuorosceneo assays
Green monkey kidnev COS-1 cells and human cervix carcinoma 
HeLa ceils were grown in DMHM containiim KK< fetal calf 
serum and were transiently transfected by eleetro|x>ration in 0.4 cm 
cuvettes (Eurogentec) (125 |il\ 300 V), using a Hio-Rad Gene 
Pulser apparatus. Transfected COS-1 or I lei.a cells or synovial 
sarcoma cells were grown on poly-i.-Iysine (Sigma) coated 
coverslips for 40-48 h (16-18 h for SYT-transfecled cells), fixed 
with 3% formaldehyde in PBS for 30 min at room temperature, 
washed three times with PBSTsolution (PBS, 0.05'7 Tween 20), 
permeahilized with methanol at - 2 0  "C for 10 min. and washed 
once with PBST. The coverslips were then incubated with 
primary antibody for I h at room temperature, washed three limes 
for 5 min with PBST, and incubated with secondary antibody for 
30 min at room temperature. The primary and secondary 
antibodies were diluted in PBST and Kr of normal serum of the 
species from which the secondary anti hodv is derived, As primary
*  m \  y
antibodies we used the affinity-purified polyclonal antibodies 
CM  (1:50 dilution), RA2009 (1:100), B39 ( I¡5(H)), and OX) ( I: 100) 
and the monoclonal antibodies P5D4 (anti-VSV, 1:1000} and (V15 
(anti-FLAG, 1:100). For co-localization studies, the following
Vm
monoclonal antibodies were used: 4G3 (anti'U2 B'), C)A9 
(anti-U 1-A/U2-B') (44), Y12 (anti-Sm) (45), anti-SC '35 (46), and 
5EI0 (anti-PML) (47). As secondary antibodies, we used FITC- 
conjugated swine anti-rabbit ( 1:100 dilution) iw rabbit anti-mouse 
(1:100 dilution) IuG (Dako), and for double immunotluorescence
staining, Iexas Red-conjugated Goal anti-mouse IgG (.1:300 
dilution) (Jackson Imnutnoresearchh After washing three times 
with PBST, the coverslips weir counterstained with 0.1 Jig/ml of 
DAPI (Serva) in PBS for 15 min. washed two times with PBS, 
dehydrated with water and methanol and mounted in Mowiol 
(Hoechst). Slides were visualized under a Zeiss Axiophot cpifiuores- 
eence microscope equipjxxl with appropriate fillers and digital 
images were recorded using a Photometries high-|>erlbnuanee
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(11250/A cooled CCD-eamera interfaced onto a Macintosh
Quadra l)50 computer. The images were displayed in red-green-
blue pseudocolors on the computer screen using the image
analysis and processing software program BDS-image (Biological
Doled ion .Systems). C onlocal laser-scanning microscopy was
performed using a Bio-Rad MRCI (XX) Laser Scanning microscope.
Digitalized images were processed using the Adobe Photoshop 
soli ware package.
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